Funapide
http://dbpedia.org/resource/Funapide an entity of type: Thing
Funapide (INN) (former developmental code names TV-45070 and XEN402) is a novel analgesic under development by (formerly in partnership with Teva Pharmaceutical Industries) for the treatment of a variety of chronic pain conditions, including osteoarthritis, neuropathic pain, postherpetic neuralgia, and erythromelalgia, as well as dental pain. It acts as a small-molecule Nav1.7 and Nav1.8 voltage-gated sodium channel blocker. Funapide is being evaluated in humans in both oral and topical formulations, and as of July 2014, has reached phase IIb clinical trials.
rdf:langString
rdf:langString
Funapide
xsd:integer
43348294
xsd:integer
1082990349
rdf:langString
None
xsd:integer
22
xsd:integer
1259933
xsd:integer
34500834
xsd:integer
3
xsd:integer
14
xsd:integer
-1
rdf:langString
D11156
xsd:integer
1
xsd:integer
5
xsd:integer
49836093
rdf:langString
C1C2C5=CC6=COCO6
xsd:integer
1
rdf:langString
NEBUOXBYNAHKFV-NRFANRHFSA-N
rdf:langString
A5595LHJ2L
xsd:integer
250
rdf:langString
Funapide (INN) (former developmental code names TV-45070 and XEN402) is a novel analgesic under development by (formerly in partnership with Teva Pharmaceutical Industries) for the treatment of a variety of chronic pain conditions, including osteoarthritis, neuropathic pain, postherpetic neuralgia, and erythromelalgia, as well as dental pain. It acts as a small-molecule Nav1.7 and Nav1.8 voltage-gated sodium channel blocker. Funapide is being evaluated in humans in both oral and topical formulations, and as of July 2014, has reached phase IIb clinical trials.
xsd:nonNegativeInteger
4333
xsd:string
1259933-16-8
xsd:string
A5595LHJ2L
xsd:string
D11156
xsd:string
49836093